Ron A. Andrews

Ronnie has close to 30 years of experience in the Global Clinical and Molecular Diagnostics industry. In his early years in diagnostics, he worked for Abbott Diagnostics in various roles in infectious disease and virology testing. From 2000 – 2005, He served as the CCO for Roche Molecular Diagnostics during which time he led the global deployment of HIV Viral Load and Genotype testing into over 40 countries. Ronnie served as the President of the Genetic Science Division for Thermo Fisher Scientific. In this role, Ronnie oversaw the integration of Life Technologies’ genetic platforms, including Life’s chip-based Next Generation Sequencing Technology, Ion Torrent, which today is the market leader in genomic profiling for oncology therapeutic decisions. Prior to this Ronnie held a number of other high-profile executive roles including President of the Medical Sciences Venture within the Life Technologies Corporation, and he served as Chief Executive Officer of Clarient, a public company on the NASDAQ which was sold to General Electric Healthcare in December 2010.